Objective
The main aim of the present project is to provide the first description of embryonic megakaryocyte function during vascular development and maintenance. The recent description of embryonic megakaryocytes existence together with the presence of vascular defects in all mouse mutant models that lack embryonic megakaryocytes suggests that a cellular interaction between embryonic megakaryocytes and endothelium is essential for the correct patterning and stability of the vasculature. The vascular system is the first organ to become functional in the embryo and its regulatory mechanisms are of ultimate medical importance in cancer, development, homeostasis, healing and regeneration. Likewise, blood and endothelium develop in close association and it is surprising to realize how little we know on how specific haematopoietic lineages support the development of a functional vasculature. We will address this important issue by characterizing the function of Meis1 in the megakaryocytic lineage and of the megakaryocytic lineage in vascularization. Meis1 mutant mice are the only known mutant mice that lack embryonic megakaryocytes without another apparent haematopoietic deficiency. Therefore, Meis1 null mice present a unique opportunity to investigate this common denominator – absence of megakaryocytes – on all haematopoietic mutants that present vascular defects. We will achieve this goal by: 1) a detailed characterization of the Meis1 vascular defect using histological approaches and optical projection tomography; 2) imaging the behaviour and interaction of the megakaryocyte cellular equivalents and the endothelium in live zebrafish embryos; and 3) establish the role of Meis1 and of embryonic megakaryocytes in embryonic vascularization through the targeted elimination of this lineage, the rescue of Meis1 null vascular phenotype by megakaryocyte progenitor transplantation and by the conditional reactivation of Meis function in the megakaryocytic lineage of Meis1 null embryos.
Fields of science (EuroSciVoc)
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: https://op.europa.eu/en/web/eu-vocabularies/euroscivoc.
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: https://op.europa.eu/en/web/eu-vocabularies/euroscivoc.
- medical and health sciences clinical medicine oncology
- medical and health sciences clinical medicine transplantation
- medical and health sciences clinical medicine embryology
- medical and health sciences basic medicine physiology homeostasis
You need to log in or register to use this function
We are sorry... an unexpected error occurred during execution.
You need to be authenticated. Your session might have expired.
Thank you for your feedback. You will soon receive an email to confirm the submission. If you have selected to be notified about the reporting status, you will also be contacted when the reporting status will change.
Programme(s)
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
Topic(s)
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Call for proposal
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
FP7-PEOPLE-2009-IEF
See other projects for this call
Funding Scheme
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
Coordinator
28029 Madrid
Spain
The total costs incurred by this organisation to participate in the project, including direct and indirect costs. This amount is a subset of the overall project budget.